Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

Supplemental figure 1 relative survival by year of diagnosis and extent of MCC at presentation. Supplemental figure 2 24-month overall survival by year of diagnosis and extent of Merkel cell carcinoma at presentation.